Real-world clinical outcomes of biologic-naive non-complicated Crohn's disease patients treated with vedolizumab: Results from the EVOLVE study

被引：0
|
作者：
Yarur, A. [1 ]
Mantzaris, G. J. [2 ]
Kopylov, U. [3 ]
Bassel, M. [4 ]
Brett, N. [4 ]
Kim, H. [5 ]
Lopez, C. [6 ]
Saha, S. [7 ]
Kifnidi, C. [8 ]
Agboton, C. [9 ]
Adsul, S. [9 ]
Demuth, D. [10 ]
Luo, M. [11 ]
Wang, S. [11 ]
Bressler, B. [12 ]
机构：
[1] Med Coll Wisconsin, Gastroenterol, Milwaukee, WI 53226 USA
[2] Evangelismos Med Ctr, Gastroenterol, Athens, Greece
[3] Sheba Med Ctr, Gastroenterol, Tel Aviv, Israel
[4] Evidera, Real World Evidence, Montreal, PQ, Canada
[5] Evidera, Data Analyt, Waltham, MA USA
[6] Takeda Pharmaceut USA Inc, Med Affairs, Deerfield, IL USA
[7] Takeda Canada Inc, Med Affairs, Oakville, ON, Canada
[8] Takeda Hellas SA, Med Affairs, Athens, Greece
[9] Takeda Pharmaceut Int AG, Global Med Affairs, Zurich, Switzerland
[10] Takeda Pharmaceut Int, Evidence Generat & Publicat, Singapore, Singapore
[11] Takeda Pharmaceut Int, Global Outcomes Res, Boston, MA USA
[12] St Pauls Hosp, Gastroenterol, Vancouver, BC, Canada
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P387
引用
收藏
页码：S360 / S361
页数：2
相关论文
共 50 条
  • [21] Vedolizumab Outcomes in Real-world Bio-naive Ulcerative Colitis and Crohn's Disease Patients (EVOLVE) in North America
    Yarur, Andres
    Bassel, Marielle
    Stein, Dara
    Kim, Hankyul
    Radulescu, Gabriela
    Lopez, Claudia
    Lissoos, Trevor
    Demuth, Dirk
    Bressler, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S374 - S374
  • [22] Comparison of real-world treatment outcomes with infliximab vs. vedolizumab in biologic-naive patients with inflammatory bowel disease
    Latremouille-Viau, D.
    Burne, R.
    Shi, S.
    Adsul, S.
    Patel, H.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S295 - S296
  • [23] Comparison of surgery rates in biologic-naive patients with Crohn's disease treated with vedolizumab or ustekinumab: findings from SOJOURN
    Vu, Michelle
    Ghosh, Sabyasachi
    Umashankar, Kandavadivu
    Weber, Laura
    Landis, Christina
    Candela, Ninfa
    Chastek, Benjamin
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [24] Hospitalisations and characteristics of patients with ulcerative colitis and Crohn's disease treated with vedolizumab in real-world clinical practice: results from a multicentre study
    Reynolds, M.
    Alam, N.
    Raluy, M.
    Gardstein, B.
    O'Hara, D.
    Smyth, M.
    Khalid, J. M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S214 - S214
  • [25] Hospitalisations, Flares, and Corticosteroid Use Outcomes in Biologic-Naive Patients with Ulcerative Colitis and Crohn's Disease Initiating Vedolizumab
    Alam, Naufil
    Raluy-Callado, Mireia
    Donaldson, Robert
    Kaviya, Arpeat
    Khalid, Javaria
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S26 - S27
  • [26] Comparison of Surgery Rates in Biologic-Naive Patients With Crohn's Disease Who Were Treated With Vedolizumab or Ustekinumab: Findings From SOJOURN
    Vu, Michelle
    Ghosh, Sabyasachi
    Umashankar, Kandavadivu
    Chastek, Benjamin
    Candela, Ninfa
    Weber, Laura A.
    Landis, Christina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S715 - S716
  • [27] USE OF DIFFERENT STATISTICAL APPROACHES TO COMPARE REAL-WORLD OUTCOMES ASSOCIATED WITH VEDOLIZUMAB VERSUS INFLIXIMAB IN BIOLOGIC-NAIVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Latremouille-Viau, D.
    Burne, R.
    Shi, S.
    Patel, H.
    VALUE IN HEALTH, 2019, 22 : S178 - S178
  • [28] Patient Characteristics and Clinical Outcomes in Biologic-Naive Patients With Crohn's Disease Initiating Vedolizumab Treatment Early Versus Later After Diagnosis
    Haridarshan, Patel
    Mireia, Raluy-Callado
    Ariel, Berger
    Robert, Donaldson
    Sharvari, Bhurke
    Mona, Khalid Javaria
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S8 - S8
  • [29] Real-world clinical outcomes and healthcare costs in patients with Crohn's disease treated with vedolizumab versus ustekinumab in the United States
    Chiorean, Michael
    Jiang, Jeanne
    Candela, Ninfa
    Chen, Grace
    Romdhani, Hela
    Latremouille-Viau, Dominick
    Shi, Sherry
    Bungay, Rebecca
    Guerin, Annie
    Fan, Tao
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (05) : 877 - 885
  • [30] REAL-WORLD EFFECTIVENESS OF FIRST-LINE BIOLOGIC VEDOLIZUMAB IN CROHN'S DISEASE: ANALYSIS OF HIGHER TREATMENT EFFECT SUBPOPULATION FROM THE EVOLVE STUDY
    Yarur, Andres
    Bressler, Brian
    Wang, Song
    Adsul, Shashi
    Kamble, Pravin
    Luo, Michelle
    Cook, Erin
    Sajeev, Gautam
    Dieye, Ibou
    Mantzaris, Gerassimos J.
    GASTROENTEROLOGY, 2021, 160 (06) : S4 - S4
12345